These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8299691)
1. Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine. Hellman L Eur J Immunol; 1994 Feb; 24(2):415-20. PubMed ID: 8299691 [TBL] [Abstract][Full Text] [Related]
2. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses. Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083 [TBL] [Abstract][Full Text] [Related]
3. Genetic allergen modification in the development of novel approaches to specific immunotherapy. Mutschlechner S; Deifl S; Bohle B Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein. Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510 [TBL] [Abstract][Full Text] [Related]
5. Allergen-specific immunosuppression by ovalbumin fused with diphtheria toxin in mice sensitized with albumins of different origin. Lee BK; Yoo JE; Jang YS; Kim JY; Hong CS; Ro JY Clin Exp Allergy; 2004 Oct; 34(10):1642-8. PubMed ID: 15479282 [TBL] [Abstract][Full Text] [Related]
6. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531 [TBL] [Abstract][Full Text] [Related]
7. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. Christensen LH; Holm J; Lund G; Riise E; Lund K J Allergy Clin Immunol; 2008 Aug; 122(2):298-304. PubMed ID: 18572230 [TBL] [Abstract][Full Text] [Related]
8. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors. Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345 [TBL] [Abstract][Full Text] [Related]
9. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. Edlmayr J; Niespodziana K; Linhart B; Focke-Tejkl M; Westritschnig K; Scheiblhofer S; Stoecklinger A; Kneidinger M; Valent P; Campana R; Thalhamer J; Popow-Kraupp T; Valenta R J Immunol; 2009 May; 182(10):6298-306. PubMed ID: 19414783 [TBL] [Abstract][Full Text] [Related]
10. Attainments in atop: special aspects of allergy and IgE. Milgrom H Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775 [TBL] [Abstract][Full Text] [Related]
11. Induction of an auto-anti-IgE response in rats. II. Effects on mast cell populations. Marshall JS; Prout SJ; Jaffery G; Bell EB Eur J Immunol; 1987 Apr; 17(4):445-51. PubMed ID: 3494616 [TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation. Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696 [TBL] [Abstract][Full Text] [Related]
13. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy. Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901 [TBL] [Abstract][Full Text] [Related]
14. Structural, immunological and functional properties of natural recombinant Pen a 1, the major allergen of Brown Shrimp, Penaeus aztecus. Reese G; Schicktanz S; Lauer I; Randow S; Lüttkopf D; Vogel L; Lehrer SB; Vieths S Clin Exp Allergy; 2006 Apr; 36(4):517-24. PubMed ID: 16630158 [TBL] [Abstract][Full Text] [Related]
15. [The clinical picture is the most important reason to screen for the presence of allergen-specific IgE in children]. Bruijnzeel-Koomen CA Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2248-50. PubMed ID: 17987889 [TBL] [Abstract][Full Text] [Related]
16. Reversed anaphylaxis with anti-IgE on mouse and rat mast cells. Wyczółkowska J; Brzezińska-Błaszczyk E; Michoń T; Maśliński C Arch Immunol Ther Exp (Warsz); 1980; 28(4):559-64. PubMed ID: 6161595 [TBL] [Abstract][Full Text] [Related]
17. Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition. Hayek B; Vangelista L; Pastore A; Sperr WR; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R J Immunol; 1998 Dec; 161(12):7031-9. PubMed ID: 9862740 [TBL] [Abstract][Full Text] [Related]
18. [Anti-IgE--a new treatment for allergic diseases]. Berkun Y; Shalit M Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220 [TBL] [Abstract][Full Text] [Related]
19. Bicistronic expression plasmid encoding allergen and anti-IgE single chain variable fragment antibody as a novel DNA vaccine for allergy therapy and prevention. Bandbon Balenga NA; Thalhamer J; Weiss R Med Hypotheses; 2006; 67(1):71-4. PubMed ID: 16513289 [TBL] [Abstract][Full Text] [Related]
20. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents. Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]